NCT03178409

Combined HCC-MFCCC

Survival After Hepatectomy for Combined Hepatocellular Cholagiocarcinoma

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 100 (actual)
• Sponsor: University of Milan · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Combined hepatocellular and mass-forming cholangiocarcinoma (cHCC-MFCCC) is a rare tumor. The aim of this study was the analysis of the outcome comparing such tumor with classic hepatocellular carcinoma (HCC) and mass-forming cholangiocarcinoma (MFCCC).

Detailed description

The institutional prospectively maintained database was queried, and 20 patients with cHCC-MFCCC were identified. A 2:1 match was performed with 40 patients operated in the same period for HCC, and with 40 operated for MFCCC. Only T1 or T2 patients N0 M0 were considered. Primary endpoint was the overall survival (OS) and disease-free survival (DFS).

Conditions

• Liver Carcinoma
• Hepatocellular Carcinoma
• Cholangiocarcinoma
• Surgery

Interventions

Type	Name	Description
PROCEDURE	Hepatectomy	Removal of a part of the liver

Timeline

• Start date: 2004-01-01
• Primary completion: 2014-12-31
• Completion: 2017-05-15
• First posted: 2017-06-06
• Last updated: 2017-06-06